These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12894573)

  • 1. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer.
    Kelley JR; Fraser MM; Hubbard JM; Watson DK; Cole DJ
    Anticancer Res; 2003; 23(3A):2007-13. PubMed ID: 12894573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer.
    Kelley JR; Brown JM; Frasier MM; Baron PL; Schweinfest CW; Vournakis JN; Watson DK; Cole DJ
    Surgery; 2000 Aug; 128(2):353-60. PubMed ID: 10923016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.
    Yan Y; Rubinchik S; Wood AL; Gillanders WE; Dong JY; Watson DK; Cole DJ
    Mol Ther; 2006 Feb; 13(2):357-65. PubMed ID: 16226492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
    Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
    Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.
    Yan Y; Rubinchik S; Watson PM; Kelley JR; Fraser MM; Wood AL; Dong JY; Gillanders WE; Boylan AM; Watson DK; Cole DJ
    Mol Ther; 2005 Mar; 11(3):363-72. PubMed ID: 15727932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CaSm/gemcitabine chemo-gene therapy leads to prolonged survival in a murine model of pancreatic cancer.
    Kelley JR; Fraser MM; Schweinfest CW; Vournakis JN; Watson DK; Cole DJ
    Surgery; 2001 Aug; 130(2):280-8. PubMed ID: 11490361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
    Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
    J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaSm: an Sm-like protein that contributes to the transformed state in cancer cells.
    Schweinfest CW; Graber MW; Chapman JM; Papas TS; Baron PL; Watson DK
    Cancer Res; 1997 Jul; 57(14):2961-5. PubMed ID: 9230209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
    Miura Y; Ohnami S; Yoshida K; Ohashi M; Nakano M; Ohnami S; Fukuhara M; Yanagi K; Matsushita A; Uchida E; Asaka M; Yoshida T; Aoki K
    Cancer Lett; 2005 Jan; 218(1):53-62. PubMed ID: 15639340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
    Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
    Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular target-based therapy of pancreatic cancer.
    Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
    Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer.
    Lefter LP; Dima S; Sunamura M; Furukawa T; Sato Y; Abe M; Chivu M; Popescu I; Horii A
    Cancer Gene Ther; 2009 Feb; 16(2):137-48. PubMed ID: 18772901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy developments for pancreatic cancer.
    Bhattacharyya M; Lemoine NR
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
    Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral gene therapy for pancreatic cancer: where do we stand?
    Kuhlmann KF; Gouma DJ; Wesseling JG
    Dig Surg; 2008; 25(4):278-92. PubMed ID: 18635930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
    Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
    Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
    Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
    Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.